Cancer Stem Cell News Volume 3.00 | Jan 8 2014

    0
    311

    Cancer Stem Cell News 3.00 January 8, 2014

    Cancer Stem Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Cancer Stem Cell News on Twitter

     
    TOP STORY
    Curcumin Targets Breast Cancer Stem-Like Cells with Microtentacles that Persist in Mammospheres and Promote Attachment
    Researchers report that breast cancer cell lines with more stem-like properties display higher levels of microtentacles, a type of tubulin-based protrusion of the plasma cell membrane which forms on detached or suspended cells and aid in cell reattachment. [Cancer Res] Abstract
    Learn More: Column-Free Enrichment of Mouse Mammary Stem & Progenitor Cells

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Tumor Suppressor Alterations Cooperate to Drive Aggressive Mesotheliomas with Enriched Cancer Stem Cells via a p53-miR34a-c-Met Axis
    Scientists demonstrated that germline knockout of one allele of NF2 and CDKN2A causes accelerated onset and progression of asbestos-induced malignant mesothelioma compared to asbestos-exposed Nf2+/- or wild-type mice. [Cancer Res] Abstract

    CD44 Expressed on Cancer-Associated Fibroblasts Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor Microenvironment
    Scientists showed that cancer-associated fibroblasts (CAFs) support tumor growth in vivo and maintain the stemness of cancer stem/initiating cells in an in vitro model using an established CAF cell line. [Stem Cells]
    Full Article

    Selective Non-Nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including Cancer Stem Cells
    Through a process of hit-to-lead optimization, researchers report the discovery of compound 5 as potent non-nucleoside DNA methyltransferase inhibitors, and selective towards other AdoMet-dependent protein methyltransferases. [J Med Chem] Abstract

    Elevated Intrinsic Cancer Stem Cell Population in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma
    Because the prognoses of patients with human papillomavirus (HPV) 16-positive and HPV-negative head and neck squamous cell carcinoma are distinct, scientists sought to determine whether differences in the number of cancer stem cells could account for this clinical observation. [Cancer] Abstract

    Progesterone Stimulates Progenitor Cells in Normal Human Breast and Breast Cancer Cells
    Scientists showed that progesterone stimulates progenitor cells in human breast cancer cell lines and expands the cancer stem cell population via increasing the stem-like CD44+ population. [Breast Cancer Res Treat] Abstract

    Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
    Investigators deciphered the functional impact of Syndecan-1 knockdown using RNA interference on the breast cancer stem cell phenotype of human triple-negative MDA-MB-231 and hormone receptor-positive MCF-7 cells in vitro employing an analytical flow cytometric approach. [PLoS One] Full Article

    Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells
    Scientists demonstrated that STAT3 physically interacts with CD44 and NF-kB and activates the catalytic subunit of telomerase in human breast cancer stem cells. [PLoS One] Full Article

    Studies on MicroRNAs that Are Correlated with the Cancer Stem Cells in Chronic Myeloid Leukemia
    The authors aimed to detect the miRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia (CML) to provide theoretical basis for clinical application. They first analyzed microRNA expression profiles of CML leukemia patients compared with normal controls by microarray analysis and validated the results by real-time PCR. [Mol Cell Biochem] Abstract

    Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell Immunotherapy
    Autologous monocyte-derived dendritic cells pulsed with the CD133-405 or CD133-753 peptides generated cytotoxic T cells that efficiently recognized the CD133 epitopes presented in T2 HLA-A*0201 cells and specifically lysed CD133+ HLA-A*0201+ glioblastoma multiforme cancer stem cells. [Stem Cells Transl Med]
    Abstract | Press Release

    Culture Human Glioma-Derived Tumorspheres with NeuroCultâ„¢ - View Publications

     
    REVIEWS
    Oncogenic Somatic Events in Tissue-Specific Stem Cells: A Role in Cancer Recurrence?
    Emerging evidence suggests that tissue-specific stem cells (TSSCs) are implicated in malignancies, with several theories being proposed and tested, including many attempts to identify the cells of origin and studies deigned to understand how TSSCs participate in age-related increase in cancer risk. [Ageing Res Rev] Abstract

    Kinase-Inhibitor-Insensitive Cancer Stem Cells in Chronic Myeloid Leukemia
    This review focuses on the mechanisms of leukemic stem cells insensitivity to tyrosine kinase inhibitors and on the strategies to obtain synthetic lethality with combination therapies. [Exp Opin Biol Ther] Abstract

    Visit our reviews page to see a complete list of reviews in the cancer stem cell research field.

    Enter to Win: Free ISCT 2014 Conference Registration in Paris, France!

     
    INDUSTRY NEWS
    Stanford Shares in $540 Million Gift from Ludwig Cancer Research
    The Stanford University School of Medicine has received $90 million from Ludwig Cancer Research on behalf of its founder, Daniel K. Ludwig, to support the school’s innovative work in cancer stem cells, which are believed to drive the growth of many cancers. [Stanford University] Press Release

    Weill Cornell Medical College Receives $75 Million Gift from Sandra and Edward Meyer and the Sandra and Edward Meyer Foundation to Create the Meyer Cancer Center at Weill Cornell
    Weill Cornell Medical College announced that it has received a $75 million gift from Sandra and Edward Meyer and the Sandra and Edward Meyer Foundation to expand and enhance the medical college’s distinguished cancer research and care programs. [Weill Cornell Medical College] Press Release

    From our sponsor: Free mouse hematopoietic progenitors wallchart. Request your copy.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Anti-Cancer Therapeutics: From Research to Trials to Treatment
    May 14, 9:00 to 17:00 GMT
    London, United Kingdom

    Visit our events page to see a complete list of events in the cancer stem cell community.

     
    JOB OPPORTUNITIES
    NEW PhD Candidates – Stem Cells and Biomedical Engineering (Queensland University of Technology)

    NEW Senior Research Scientist – Cancer Stem Cell Biology (Aurora Health Care)

    NEW Postdoctoral Position – Stem Cell and Cancer (Harvard Medical School)

    Research Associate – Stem Cell & Leukemia Epigenetic (King’s College London)

    Postdoctoral Position – Stem Cells and Bioengineering (Queensland University of Technology/Translational Research Institute)

    Clinical MD – Clinical Development Program for Oncology and Autoimmune Diseases (Immunomedics, Inc.)

    Chief Medical Officer – Novel Therapeutics in Oncology and Autoimmune Disease (Immunomedics, Inc.)

    Postdoctoral Position – Nervous System Development and Tumor Biology (Karolinska Institutet)


    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!

    Comments or Suggestions? Email Comments or suggestions? Submit your feedback here

    Learn more about Cancer Stem Cell News: Archives | Events | Contact Us